Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Ethics of mental enhancement: do adults taking ADHD medication have an unfair advantage?

Thomas JD.

Mod Healthc. 2013 Jul 8;43(27):27. No abstract available.

PMID:
23878921
2.

A university physician's duty to nonpatient students.

Geppert C.

Virtual Mentor. 2012 May 1;14(5):378-82. doi: 10.1001/virtualmentor.2012.14.5.ecas3-1205. No abstract available.

3.

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.

Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.

Curr Med Res Opin. 2010 Apr;26(4):977-89. doi: 10.1185/03007991003673617.

PMID:
20178404
4.

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63.

PMID:
10591302
5.

Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.

Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.

Pediatrics. 2008 Jan;121(1):e65-72. doi: 10.1542/peds.2007-0383.

PMID:
18166546
6.

Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines.

Bilenberg N, Gillberg C, Houmann T, Kadesj√ł B, Lensing MB, Plessen KJ, Strand G, Thomsen PH, Worning A.

Nord J Psychiatry. 2012 Feb;66(1):70-1. doi: 10.3109/08039488.2011.593102. Epub 2011 Sep 29. No abstract available.

PMID:
21958313
7.

Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications.

Bruckner TA, Hodgson A, Mahoney CB, Fulton BD, Levine P, Scheffler RM.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):442-9. doi: 10.1002/pds.2264. Epub 2011 Oct 24.

PMID:
22021031
8.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
9.

Primary care providers often first line of ADHD treatment.

Mitchell L.

J Okla State Med Assoc. 2009 Nov;102(11):362. No abstract available.

PMID:
20034251
10.

Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.

Molife C, Bernauer MJ, Farr AM, Haynes VS, Kelsey D.

Postgrad Med. 2012 Sep;124(5):7-22. doi: 10.3810/pgm.2012.09.2586.

PMID:
23095422
11.

Politics vs practice: commentary on the ADHD debate.

Levy F.

Aust N Z J Psychiatry. 2013 Jan;47(1):89-91. doi: 10.1177/0004867412459811. No abstract available.

PMID:
23293313
12.

Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.

Biederman J, Seidman LJ, Petty CR, Fried R, Doyle AE, Cohen DR, Kenealy DC, Faraone SV.

J Clin Psychiatry. 2008 Jul;69(7):1150-6.

13.

Moral hazard: why consequences matter.

Green D, McNeeley MF.

J Am Coll Radiol. 2012 Feb;9(2):147. doi: 10.1016/j.jacr.2011.07.008. No abstract available.

PMID:
22305702
14.

ADHD treatment--supply or demand?

Winterstein AG.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):450-1. doi: 10.1002/pds.3192. Epub 2012 Jan 31. No abstract available.

PMID:
22290762
15.

Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.

Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC.

J Dev Behav Pediatr. 2002 Feb;23(1):23-30.

PMID:
11889348
16.

Are stimulants overprescribed for youths with ADHD?

Safer DJ.

Ann Clin Psychiatry. 2000 Mar;12(1):55-62. Review.

PMID:
10798827
17.
18.

Practicing accountability in professional ethics.

d'Oronzio JC.

J Clin Ethics. 2002 Winter;13(4):359-66. No abstract available.

PMID:
12793330
19.

The care of the patient.

Barondess JA.

Pharos Alpha Omega Alpha Honor Med Soc. 2011 Summer;74(3):6-10. No abstract available.

PMID:
21877510
20.

Competing commitments in clinical trials.

Lidz CW, Appelbaum PS, Joffe S, Albert K, Rosenbaum J, Simon L.

IRB. 2009 Sep-Oct;31(5):1-6. No abstract available.

Supplemental Content

Support Center